πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8795677

Treatment methods using an F1-V plague vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8791092

Molecular tweezers for the treatment of amyloid-related diseases

The Regents of the University of California Β· Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8790878

Diagnosis and treatment of breast cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785492

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785421

Use of vitamin D in dairy mastitis treatment

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785414

Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of SjΓΆgre

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785373

Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer t

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8784881

Liposomal curcumin for treatment of diseases

The Board of Regents of the University of Texas System Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8779156

Analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8779090

Methods and compositions for the treatment of heart failure and other disorders

IRONWOOD PHARMACEUTICALS, INC. Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778997

Antiviral treatments

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778897

Method of treatment using Ξ±-1-adrenergic agonist compounds

The Regents of the University of California Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778889

Antimicrobial decapeptide oral hygiene treatment

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8778608

CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metas

The Regents of the University of California Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772238

Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765731

Benzimidazole analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759318

Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infec

University College Cardiff Consultants Limited Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759340

Benzodiazepinone compounds useful in the treatment of skin conditions

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8759325

Compositions and methods of treatment for inflammatory diseases

The Regents of the University of Oklahoma Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748408

Methods of treatment of mitochondrial disorders

The Regents of the University of California Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8747845

Methods of treatment by administering antibodies that bind colony stimulating factor 1 rec

Five Prime Therapeutics, Inc. Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8747843

Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8742141

Inhibition and treatment of prostate cancer metastasis

Northwestern University Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8740872

Magnetically-targeted treatment for cardiac disorders

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted